Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
SoundThinking
SSTI
$103M
| $1.07M | ﹤0.01% |
21,942
+2,061
| +10% | +$79.1K |
|
|
EGLE
2902
DELISTED
Eagle Bulk Shipping Inc.
EGLE
| $1.06M | ﹤0.01% |
22,478
+3,632
| +19% | +$165K |
|
2903
Qiagen
QGEN
$8.55B
| $1.06M | ﹤0.01% |
20,675
+1,200
| +6% | +$62K |
|
2904
Civista Bancshares
CIVB
$601M
| $1.06M | ﹤0.01% |
47,877
-1,425
| -3% | -$32.9K |
|
|
TLIS
2905
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $1.06M | ﹤0.01% |
6,400
+156
| +2% | +$26.5K |
|
2906
Bioventus
BVS
$893M
| $1.06M | ﹤0.01% |
60,081
+8,662
| +17% | +$140K |
|
|
INZY
2907
DELISTED
Inozyme Pharma
INZY
| $1.06M | ﹤0.01% |
61,917
+2,422
| +4% | +$42.1K |
|
2908
Clearfield
CLFD
$420M
| $1.05M | ﹤0.01% |
28,111
-27
| -0.1% | -$959 |
|
2909
Eterna Therapeutics
ERNA
$4.05M
| $1.05M | ﹤0.01% |
+8
| New | +$1.15M |
|
|
KLDO
2910
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $1.05M | ﹤0.01% |
140,478
+14,566
| +12% | +$103K |
|
|
MOFG
2911
DELISTED
MidWestOne Financial Group
MOFG
| $1.04M | ﹤0.01% |
36,288
-829
| -2% | -$25.5K |
|
2912
Hooker Furnishings Corp
HOFT
$150M
| $1.04M | ﹤0.01% |
30,084
+1,110
| +4% | +$41.4K |
|
|
CSTR
2913
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $1.04M | ﹤0.01% |
50,837
+8,935
| +21% | +$180K |
|
|
RBNC
2914
DELISTED
Reliant Bancorp, Inc. Common Stock
RBNC
| $1.04M | ﹤0.01% |
37,539
-224
| -0.6% | -$6.43K |
|
2915
Bar Harbor Bankshares
BHB
$660M
| $1.04M | ﹤0.01% |
36,279
-1,204
| -3% | -$35.5K |
|
|
IMDX
2916
Insight Molecular Diagnostics
IMDX
$149M
| $1.04M | ﹤0.01% |
9,041
-86
| -0.9% | -$8.4K |
|
2917
UFP Technologies
UFPT
$1.97B
| $1.04M | ﹤0.01% |
18,053
+855
| +5% | +$46.4K |
|
2918
Allient
ALNT
$1.47B
| $1.03M | ﹤0.01% |
29,900
+2,309
| +8% | +$81.2K |
|
2919
Evolus
EOLS
$396M
| $1.03M | ﹤0.01% |
81,654
+27,546
| +51% | +$303K |
|
2920
Biglari Holdings Class B
BH
$1.25B
| $1.03M | ﹤0.01% |
6,464
-118
| -2% | -$18.2K |
|
|
EMWP
2921
DELISTED
Eros Media World PLC
EMWP
| $1.03M | ﹤0.01% |
33,678
+16,049
| +91% | +$438K |
|
2922
Viking Therapeutics
VKTX
$3.86B
| $1.03M | ﹤0.01% |
171,539
+5,084
| +3% | +$30.2K |
|
2923
MVB Financial
MVBF
$394M
| $1.02M | ﹤0.01% |
23,977
+779
| +3% | +$31.8K |
|
2924
Willdan Group
WLDN
$1.06B
| $1.02M | ﹤0.01% |
27,082
+822
| +3% | +$31.8K |
|
2925
NI Holdings
NODK
$314M
| $1.02M | ﹤0.01% |
53,540
-3,201
| -6% | -$61.7K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.